Category:

Non-Life

Impressed with Bihar’s HIT COVID App, PM seeks details for countrywide use

Chief Minister Nitish Kumar had launched the ”HIT COVID App” on Monday to reach out to coronavirus patients undergoing treatment for the deadly disease in home isolation.

As part of the project, health workers at the grassroots level visit patients in home isolation to record their temperature and oxygen level on a daily basis, and the data is fed to the App.

read more

IMD reports new cyclone formation, Yaas, at Bay of Bengal

“Low pressure of the new cyclonic storm is expected to start forming in the Bay of Bengal by May 22. May 23 should mark depression stage, and the final cyclonic storm is expected to hit by May 24-25,” he told ANI.

The cyclone Yaas will hit the coasts of Odisha and West Bengal on May 26. Meanwhile, both the states will experience heavy rainfall from May 22 to 26.

read more

USA and China to lead global insurance industry’s growth in 2021: Allianz

the USA (+5.3%) and China (+13.4%) are likely to be the two growth engines. Following the sharp slump in the previous year, the recovery in the life segment (+5.7%) will be somewhat stronger than in the p&c segment (+4.2%).

The strong growth should continue in subsequent years, driven by the increased focus on sustainability and the further rise of the emerging markets.

Globally, average growth of over 5% over the next ten years appears possible.

read more

Less than 2 pc population affected by COVID in India, 98 pc still vulnerable: Govt

The government said that of the total population in India, 1.8 per cent has been affected by COVID-19 so far and 98 per cent of the population is still susceptible or vulnerable to the infection.

The government said a continued decline has been noted in active cases in the last 15 days. From 17.13 per cent of the total caseload reported on May 3, it has reduced to 13.3 per cent, it added.

read more

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

“Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” Paul said during a press conference.
Hours after Delhi Chief Minister Arvind Kejriwal stated that the new COVID variant detected in Singapore is “deadly for children” and may bring in third wave of the disease in the country, Paul reassured that children will not get serious COVID-19 infection, adding that the situation is being closely monitored and reports referring to the variant are being examined.

read more